Aliya Gulamhusein
- Hepatology top 1%
- Liver Diseases and Immunity 30
- Liver Disease and Transplantation 5
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 16
- Transplantation top 10%
- Surgery top 10%
- Pediatric Hepatobiliary Diseases and Treatments 12
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Transplantation: Methods and Outcomes 3
- Oncology top 10%
-
- Gallbladder and Bile Duct Disorders 13
-
- Inflammatory Bowel Disease 3
- Co-authors
- Gideon M. HirschfieldBrian D. JuranÇharles N. BernsteinGeoffrey C. NguyenKonstantinos LazaridisElizabeth J. AtkinsonKonstantinos N. LazaridisJohn E. Eaton
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Aliya Gulamhusein
36 papers receiving 968 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Hepatology 670
- Epidemiology 561
- Transplantation 42
- Surgery 506
- Oncology 239
Countries citing papers authored by Aliya Gulamhusein
This map shows the geographic impact of Aliya Gulamhusein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliya Gulamhusein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliya Gulamhusein more than expected).
Fields of papers citing papers by Aliya Gulamhusein
This network shows the impact of papers produced by Aliya Gulamhusein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliya Gulamhusein. The network helps show where Aliya Gulamhusein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aliya Gulamhusein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 13 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 22 | |
| 8 | 2022 | 28 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 3 | |
| 11 | The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. | 2019 | 3 |
| 12 | 2019 | 14 | |
| 13 | 2019 | 192 | |
| 14 | 2018 | 13 | |
| 15 | 2018 | 18 | |
| 16 | 2016 | 76 | |
| 17 | 2015 | 48 | |
| 18 | 2013 | 14 | |
| 19 | 2012 | 78 | |
| 20 | 2007 | 1 |
About Aliya Gulamhusein
Aliya Gulamhusein is a scholar working on Hepatology, Transplantation, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 980 indexed citations. Recurring topics across this work include Liver Diseases and Immunity (30 papers), Liver Disease Diagnosis and Treatment (16 papers), Gallbladder and Bile Duct Disorders (13 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers), Liver Disease and Transplantation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Inflammatory Bowel Disease (3 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Hepatology (670 citations), Epidemiology (561 citations), Transplantation (42 citations), Surgery (506 citations) and Oncology (239 citations). Aliya Gulamhusein has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Gideon M. Hirschfield, Brian D. Juran, Çharles N. Bernstein, Geoffrey C. Nguyen, Konstantinos Lazaridis, Elizabeth J. Atkinson, Konstantinos N. Lazaridis, John E. Eaton, Kris V. Kowdley and Andrew J. Muir. Their work appears in journals such as Journal of Hepatology, Liver International, Hepatology, JHEP Reports and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.